These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36869766)

  • 1. SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout.
    Shin SS; Bender M; Malherbe DC; Vasquez H; Doratt BM; Messaoudi I
    Biol Res Nurs; 2023 Oct; 25(4):505-515. PubMed ID: 36869766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines.
    Gehring S; Kowalzik F; Okasha O; Engelmann T; Schreiner D; Jensen C; Mähringer-Kunz A; Hartig-Merkel W; Mai Phuong Tran T; Oostvogels C; Verstraeten T
    PLoS One; 2024; 19(1):e0294025. PubMed ID: 38289913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
    Plumb ID; Fette LM; Tjaden AH; Feldstein L; Saydah S; Ahmed A; Link-Gelles R; Wierzba TF; Berry AA; Friedman-Klabanoff D; Larsen MP; Runyon MS; Ward LM; Santos RP; Ward J; Weintraub WS; Edelstein S; Uschner D
    Vaccine; 2023 Apr; 41(15):2596-2604. PubMed ID: 36932031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers].
    Ersoy L; Tezcan Ülger S; Gülbudak H; Yaşar N; Yapıcı G; Aslan G
    Mikrobiyol Bul; 2022 Jan; 56(1):114-123. PubMed ID: 35088965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile.
    Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM
    BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low SARS-CoV-2 infection rates and high vaccine-induced immunity among German healthcare workers at the end of the third wave of the COVID-19 pandemic.
    Brehm TT; Thompson M; Ullrich F; Schwinge D; Addo MM; Spier A; Knobloch JK; Aepfelbacher M; Lohse AW; Lütgehetmann M; Schulze Zur Wiesch J
    Int J Hyg Environ Health; 2021 Sep; 238():113851. PubMed ID: 34601375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No seroconversion among healthcare workers exposed to SARS-CoV-2 during the early phase of the pandemic.
    Fica A; Olivares F; Navarrete M; Martínez Pizzi G; Martínez Ulloa M; Castillo Fuentevilla K; Cornejo Morales T; Miranda Torres N; Velásquez Mejías JC; Luco Palomino D; Valenzuela Schneider D; Vásquez Barría N
    Rev Med Chil; 2023 Feb; 151(1):23-31. PubMed ID: 37906743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 infection among emergency department healthcare providers in a large tertiary academic medical center following the peak of the pandemic.
    Murakami E; Ghatak-Roy A; Popova M; Gannon C; Park DE; Villani J; Liu C; Toma I; Lafleur J
    Am J Emerg Med; 2021 Feb; 40():27-31. PubMed ID: 33340874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupational risk factors for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection among healthcare personnel: A 6-month prospective analysis of the COVID-19 Prevention in Emory Healthcare Personnel (COPE) Study.
    Howard-Anderson JR; Adams C; Dube WC; Smith TC; Sherman AC; Edupuganti N; Mendez M; Chea N; Magill SS; Espinoza DO; Zhu Y; Phadke VK; Edupuganti S; Steinberg JP; Lopman BA; Jacob JT; Fridkin SK; Collins MH
    Infect Control Hosp Epidemiol; 2022 Nov; 43(11):1664-1671. PubMed ID: 35156597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection precaution adherence varies by potential exposure risks to SARS-CoV-2 and job role: Findings from a US medical center.
    Haas EJ; Kelly-Reif K; Edirisooriya M; Reynolds L; Beatty Parker CN; Zhu D; Weber DJ; Sickbert-Bennett E; Boyce RM; Ciccone EJ; Aiello AE
    Am J Infect Control; 2024 Apr; 52(4):381-386. PubMed ID: 38069921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network - 13 Academic Medical Centers, April-June 2020.
    Self WH; Tenforde MW; Stubblefield WB; Feldstein LR; Steingrub JS; Shapiro NI; Ginde AA; Prekker ME; Brown SM; Peltan ID; Gong MN; Aboodi MS; Khan A; Exline MC; Files DC; Gibbs KW; Lindsell CJ; Rice TW; Jones ID; Halasa N; Talbot HK; Grijalva CG; Casey JD; Hager DN; Qadir N; Henning DJ; Coughlin MM; Schiffer J; Semenova V; Li H; Thornburg NJ; Patel MM; ;
    MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(35):1221-1226. PubMed ID: 32881855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
    Cegolon L; Negro C; Mastrangelo G; Filon FL;
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective Longitudinal Serosurvey of Healthcare Workers in the First Wave of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic in a Quaternary Care Hospital in Munich, Germany.
    Weinberger T; Steffen J; Osterman A; Mueller TT; Muenchhoff M; Wratil PR; Graf A; Krebs S; Quartucci C; Spaeth PM; Grabein B; Adorjan K; Blum H; Keppler OT; Klein M
    Clin Infect Dis; 2021 Nov; 73(9):e3055-e3065. PubMed ID: 33388756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between personal protective equipment and SARS-CoV-2 infection risk in emergency department healthcare workers.
    Schmitz D; Vos M; Stolmeijer R; Lameijer H; Schönberger T; Gaakeer MI; de Groot B; Eikendal T; Wansink L; Ter Avest E
    Eur J Emerg Med; 2021 Jun; 28(3):202-209. PubMed ID: 33105329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study.
    Rashid-Abdi M; Krifors A; Sälléber A; Eriksson J; Månsson E
    Infect Dis (Lond); 2021 Mar; 53(3):169-175. PubMed ID: 33232190
    [No Abstract]   [Full Text] [Related]  

  • 18. SARS-CoV-2 Infection in Health Care Personnel and Their Household Contacts at a Tertiary Academic Medical Center: Protocol for a Longitudinal Cohort Study.
    Ciccone EJ; Zivich PN; Lodge EK; Zhu D; Law E; Miller E; Taylor JL; Chung S; Xu J; Volfovsky A; Beatty C; Abernathy H; King E; Garrett HE; Markmann AJ; Rebuli ME; Sellers S; Weber DJ; Reyes R; Alavian N; Juliano JJ; Boyce RM; Aiello AE
    JMIR Res Protoc; 2021 Apr; 10(4):e25410. PubMed ID: 33769944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI).
    Katz MA; Harlev EB; Chazan B; Chowers M; Greenberg D; Peretz A; Tshori S; Levy J; Yacobi M; Hirsch A; Amichay D; Weinberger R; Dor AB; Taraday EK; Reznik D; Chayat CB; Sagas D; Zvi HB; Berdinstein R; Rashid G; Avni YS; Mandelboim M; Zuckerman N; Rainy N; Akriv A; Dagan N; Kepten E; Barda N; Balicer RD
    Vaccine; 2022 Jan; 40(3):512-520. PubMed ID: 34903372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.